Clarus Therapeutics Holdings, Inc. (CRXT): Price and Financial Metrics
CRXT Price/Volume Stats
| Current price | $0.05 | 52-week high | $10.57 |
| Prev. close | $0.07 | 52-week low | $0.05 |
| Day low | $0.05 | Volume | 2,737,100 |
| Day high | $0.07 | Avg. volume | 6,391,756 |
| 50-day MA | $0.29 | Dividend yield | N/A |
| 200-day MA | $1.30 | Market Cap | 2.47M |
CRXT Stock Price Chart Interactive Chart >
Clarus Therapeutics Holdings, Inc. (CRXT) Company Bio
Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.
CRXT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -99.01% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...